Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Drame, Papa M ^a,b,h   Poinsignon, Anne ^a   Dechavanne, Célia ^c,d   Cottrell, Gilles ^c,e   Farce, Manon ^a   Ladekpo, Rodolphe ^f   Massougbodji, Achille ^f,g   Cornélie, Sylvie ^a   Courtin, David ^c,d,f   Migot Nabias, Florence ^c,d   Garcia, André ^c,d   Remoué, Franck ^a,b  

^a University de Montpellier   (France)

^b CENTRE DE RECHERCHE ENTOMOLOGIQUE DE COTONOU CREC   (Benin)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f Centre d'Etude et de Recherche sur le Paludisme Associe A la Grossesse et A l'Enfance   (Benin)

^g UNIVERSITY OF ABOMEY CALAVI   (Benin)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Africa; Anopheles bites; Biomarker of exposure; Infants; Malaria; Maternal IgG transfer; Salivary proteins

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INSECTICIDE; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; SALIVA PROTEIN;

AGE; ANOPHELES; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BED NET; BENIN; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INFANT; INSECTICIDE TREATED BED NET; MALARIA FALCIPARUM; MATERNAL BLOOD; MOSQUITO BITE; NONHUMAN; PARASITE TRANSMISSION; PLACENTAL TRANSFER; RURAL AREA; SEASONAL VARIATION; UMBILICAL CORD BLOOD; ANIMAL; BITES AND STINGS; BLOOD; CHEMISTRY; IMMUNOLOGY; MALARIA; PASSIVE IMMUNIZATION; PREGNANCY; TRANSMISSION;

ANIMALS; ANOPHELES; BIOMARKERS; BITES AND STINGS; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; MALARIA; PREGNANCY; SALIVARY PROTEINS AND PEPTIDES;

EID: 84937425911     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0800-6     Document Type: Article

References (51)

1. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J et al (2009) Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet 374:1533-1542
2. Eastman RT, Fidock DA (2009) Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol 7:864-874
3. Lengeler C (2004) Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev CD000363
4. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E et al (2005) Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2:e330
5. Cotter C, Sturrock HJ, Hsiang MS, Liu J, Phillips AA, Hwang J et al (2013) The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet 382:900-911
6. Noor AM, Kinyoki DK, Mundia CW, Kabaria CW, Mutua JW, Alegana VA et al (2014) The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity. Lancet 383:1739-1747
7. WHO (2014) World malaria report. World Health Organization, Geneva
8. Le Port A, Watier L, Cottrell G, Ouedraogo S, Dechavanne C, Pierrat C et al (2011) Infections in infants during the first 12 months of life: role of placental malaria and environmental factors. PLoS One 6:e27516
9. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M (2012) IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012:985646
10. Le Port A, Cottrell G, Martin-Prevel Y, Migot-Nabias F, Cot M, Garcia A (2012) First malaria infections in a cohort of infants in Benin: biological, environmental and genetic determinants. Description of the study site, population methods and preliminary results. BMJ Open 2:e000342
11. Beier JC, Killeen GF, Githure JI (1999) Entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Am J Trop Med Hyg 61:109-113
12. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I et al (2005) Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 102:5108-5113
13. Poinsignon A, Cornelie S, Mestres-Simon M, Lanfrancotti A, Rossignol M, Boulanger D et al (2008) Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites. PLoS One 3:e2472
14. Govella NJ, Chaki PP, Geissbuhler Y, Kannady K, Okumu F, Charlwood JD et al (2009) A new tent trap for sampling exophagic and endophagic members of the Anopheles gambiae complex. Malar J 8:157
15. Mboera LE (2005) Sampling techniques for adult Afrotropical malaria vectors and their reliability in the estimation of entomological inoculation rate. Tanzan Health Res Bull 7:117-124
16. The MalERA Consultative group on Monitoring EaS (2011) A research agenda for malaria eradication: monitoring, evaluation, and surveillance. PLoS Med 8:e1000400
17. WHO (2009) Global malaria action plan. World Health Organization, Geneva
18. Ribeiro JM, Francischetti IM (2003) Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. Annu Rev Entomol 48:73-88
19. Fontaine A, Diouf I, Bakkali N, Misse D, Pages F, Fusai T et al (2011) Implication of haematophagous arthropod salivary proteins in host-vector interactions. Parasit Vectors 4:187
20. Champagne DE (2004) Antihemostatic strategies of blood-feeding arthropods. Curr Drug Targets Cardiovasc Haematol Disord 4:375-396
21. Ribeiro JM (1995) Blood-feeding arthropods: live syringes or invertebrate pharmacologists? Infect Agents Dis 4:143-152
22. Drame PM, Machault V, Diallo A, Cornelie S, Poinsignon A, Lalou R et al (2012) IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Senegal. Malar J 11:72
23. Orlandi-Pradines E, Almeras L, de Denis Senneville L, Barbe S, Remoue F, Villard C et al (2007) Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa. Microbes Infect 9:1454-1462
24. Reunala T, Brummer-Korvenkontio H, Lappalainen P, Rasanen L, Palosuo T (1990) Immunology and treatment of mosquito bites. Clin Exp Allergy 20(Suppl 4):19-24
25. King JG, Vernick KD, Hillyer JF (2011) Members of the salivary gland surface protein (SGS) family are major immunogenic components of mosquito saliva. J Biol Chem 286:40824-40834
26. Remoue F, Cisse B, Ba F, Sokhna C, Herve JP, Boulanger D et al (2006) Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria. Trans R Soc Trop Med Hyg 100:363-370
27. Andrade BB, Rocha BC, Reis-Filho A, Camargo LM, Tadei WP, Moreira LA et al (2009) Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Malar J 8:121
28. Drame PM, Poinsignon A, Besnard P, Le Mire J, Dos-Santos MA, Sow CS et al (2010) Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control. Am J Trop Med Hyg 83:115-121
29. Rizzo C, Ronca R, Fiorentino G, Verra F, Mangano V, Poinsignon A et al (2011) Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors. PLoS One 6:e17980
30. Waitayakul A, Somsri S, Sattabongkot J, Looareesuwan S, Cui L, Udomsangpetch R (2006) Natural human humoral response to salivary gland proteins of Anopheles mosquitoes in Thailand. Acta Trop 98:66-73
31. Drame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC et al (2010) Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PLoS One 5:e15596
32. Poinsignon A, Cornelie S, Ba F, Boulanger D, Sow C, Rossignol M et al (2009) Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites. Malar J 8:198
33. Poinsignon A, Samb B, Doucoure S, Drame PM, Sarr JB, Sow C et al (2010) First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites. Trop Med Int Health 15:1198-1203
34. Drame PM, Diallo A, Poinsignon A, Boussari O, Dos Santos S, Machault V et al (2013) Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker. PLoS One 8:e66354
35. Damien GB, Djenontin A, Rogier C, Corbel V, Bangana SB, Chandre F et al (2010) Malaria infection and disease in an area with pyrethroid-resistant vectors in southern Benin. Malar J 9:380
36. Djenontin A, Bio-Bangana S, Moiroux N, Henry MC, Bousari O, Chabi J et al (2010) Culicidae diversity, malaria transmission and insecticide resistance alleles in malaria vectors in Ouidah-Kpomasse-Tori district from Benin (West Africa): A pre-intervention study. Parasit Vectors 3:83
37. Le Port A, Cottrell G, Martin-Prevel Y, Migot-Nabias F, Cot M, Garcia A (2012) First malaria infections in a cohort of infants in Benin: biological, environmental and genetic determinants. Description of the study site, population methods and preliminary results. BMJ Open 2:e000342
38. Cottrell G, Kouwaye B, Pierrat C, Le Port A, Bouraima A, Fonton N et al (2012) Modeling the influence of local environmental factors on malaria transmission in Benin and its implications for cohort study. PLoS One 7:e28812
39. Ellinger I, Fuchs R (2012) HFcRn-mediated transplacental immunoglobulin G transport: protection of and threat to the human fetus and newborn. Wien Med Wochenschr 162:207-213
40. Lisciandro JG, van den Biggelaar AH (2010) Neonatal immune function and inflammatory illnesses in later life: lessons to be learnt from the developing world? Clin Exp Allergy 40:1719-1731
41. Martin R, Nauta AJ, Ben Amor K, Knippels LM, Knol J, Garssen J (2010) Early life: gut microbiota and immune development in infancy. Benef Microbes 1:367-382
42. Rogier C (2003) Childhood malaria in endemic areas: epidemiology, acquired immunity and control strategies (in French). Med Trop (Mars) 63:449-464
43. Carnevale P, Frezil JL, Bosseno MF, Le Pont F, Lancien J (1978) The aggressiveness of Anopheles gambiae A in relation to the age and sex of the human subjects (in French). Bull World Health Organ 56:147-154
44. Geissbuhler Y, Chaki P, Emidi B, Govella NJ, Shirima R, Mayagaya V et al (2007) Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, Tanzania. Malar J 6:126
45. Deloron P, Dubois B, Le Hesran JY, Riche D, Fievet N, Cornet M et al (1997) Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection. Clin Exp Immunol 110:212-218
46. Costa-Carvalho BT, Vieria HM, Dimantas RB, Arslanian C, Naspitz CK, Sole D et al (1996) Transfer of IgG subclasses across placenta in term and preterm newborns. Braz J Med Biol Res 29:201-204
47. Andrade BB, Barral-Netto M (2011) Biomarkers for susceptibility to infection and disease severity in human malaria. Mem Inst Oswaldo Cruz 106(Suppl 1):70-78
48. De Serres G, Joly JR, Fauvel M, Meyer F, Masse B, Boulianne N (1997) Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles. Vaccine 15:620-623
49. Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P (2010) Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ 340:c1626
50. Dechavanne C, Guillonneau F, Chiappetta G, Sago L, Lévy P, Salnot V et al (2012) Mass spectrometry detection of G3 m and IGHG3 alleles and follow-up of differential mother and neonate IgG3. PLoS One 7:e46097
51. Kinyanjui SM, Bull P, Newbold CI, Marsh K (2003) Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis 187:667-674